Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis E Virus Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05808166
What this trial is testing

Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women

Who this might be right for
Hepatitis E Infection
International Vaccine Institute 2,358
Testing effectiveness (Phase 2)Looking for participantsNCT06306196
What this trial is testing

Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children

Who this might be right for
Hepatitis E Virus Infection
International Vaccine Institute 1,040
Testing effectiveness (Phase 2)Ended earlyNCT02604212
What this trial is testing

A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B
Arrowhead Pharmaceuticals 32
Not applicableStudy completedNCT05300425
What this trial is testing

Seroprevalence of Leptospirosis in Val Müstair, Switzerland

Who this might be right for
LeptospirosisHepatitis E Virus InfectionTularemia
University Hospital, Basel, Switzerland 258
Testing effectiveness (Phase 2)Study completedNCT03282474
What this trial is testing

HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)

Who this might be right for
Hepatitis EHepatitis Chronic Viral
Hannover Medical School 10
Testing effectiveness (Phase 2)Study completedNCT00034359
What this trial is testing

Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Alexion Pharmaceuticals, Inc. 79
Post-approval studies (Phase 4)Study completedNCT03168412
What this trial is testing

A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)

Who this might be right for
Hepatitis E
Xiamen Innovax Biotech Co., Ltd 125
Post-approval studies (Phase 4)UnknownNCT01906580
What this trial is testing

Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Beijing 302 Hospital 105
Not applicableUnknownNCT05976594
What this trial is testing

Long-term Effectiveness of a Recombinant Hepatitis E Vaccine

Who this might be right for
Hepatitis E
Xiamen University 2,900
Not applicableStudy completedNCT04670419
What this trial is testing

Morbidity and Mortality of Hepatitis E Virus Infections in Belgium

Who this might be right for
Hepatitis E
University Hospital, Antwerp 280
Not applicableUnknownNCT05614466
What this trial is testing

The SIMPLY-B Study

Who this might be right for
Hepatitis B Virus Related Hepatocellular Carcinoma
Nadine Barnes 100
Testing effectiveness (Phase 2)Ended earlyNCT00964665
What this trial is testing

Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects

Who this might be right for
Chronic Hepatitis B
Novartis Pharmaceuticals 141
Early research (Phase 1)Study completedNCT06744686
What this trial is testing

Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients with Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (only in Participants with Chronic HBV Infection)

Who this might be right for
Chronic Hepatitis B
Suzhou HepaThera Biotech Co., Ltd. 56
Testing effectiveness (Phase 2)Looking for participantsNCT07654283
What this trial is testing

Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

Who this might be right for
Hepatitis B, Chronic
AusperBio Therapeutics Inc. 70
Post-approval studies (Phase 4)Study completedNCT02604823
What this trial is testing

Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 307
Post-approval studies (Phase 4)UnknownNCT01925820
What this trial is testing

Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
National Taiwan University Hospital 540
Early research (Phase 1)WithdrawnNCT05867056
What this trial is testing

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

Who this might be right for
Hepatitis B, Chronic
Immunocore Ltd
Post-approval studies (Phase 4)UnknownNCT03549312
What this trial is testing

Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy

Who this might be right for
HIV-1-infectionHepatitis C, ChronicMethadone Dependence+6 more
Saskatchewan Health Authority - Regina Area 25
Not applicableNot Yet RecruitingNCT06859619
What this trial is testing

Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases

Who this might be right for
LeishmaniasisLeptospirosisBrucellosis+15 more
University Hospital, Montpellier 183
Large-scale testing (Phase 3)Study completedNCT01745822
What this trial is testing

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

Who this might be right for
Hepatitis B Chronic InfectionPregnancy
Institut de Recherche pour le Developpement 654
Next Page